2,297 results on '"Chang, Sam S."'
Search Results
2. Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer
3. Quality of Life in the Phase 2/3 Trial of N-803 Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin[FIGURE DASH]Unresponsive Nonmuscle-Invasive Bladder Cancer
4. Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
5. The Role of Alumni Networks and Career Advising in Early Career Stability of Urologists: Results of a Multi-institutional Study
6. Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup.
7. Time Management
8. Estimating the Impact of the Inflation Reduction Act on the Out-of-Pocket Costs for Medicare Beneficiaries With Advanced Prostate Cancer
9. MP54-10 FEMALE UROLOGIC SURGERY GRADUATES FACE HIGHER RATES OF BURNOUT DESPITE HIGH RATES OF JOB RETENTION
10. MP39-21 ASSOCIATION BETWEEN RESIDENT IN SERVICE EXAM SCORES BY POST-GRADUATE YEAR AND BOARD QUALIFYING EXAM
11. Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology
12. PD30-03 PREDICTING RESPONSE TO INTRAVESICAL BCG IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER USING AN ARTIFICIAL INTELLIGENCE-POWERED PATHOLOGY ASSAY: DEVELOPMENT AND VALIDATION IN AN INTERNATIONAL 12 CENTER COHORT
13. PD48-01 EFFICACY OF NADOFARAGENE FIRADENOVEC-VNCG FOR PATIENTS WITH BACILLUS CALMETTE-GUÉRIN-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: FINAL RESULTS FROM A PHASE 3 TRIAL
14. PD27-12 DEVELOPMENT AND VALIDATION OF GENERALIZABLE INTERPRETABLE AI BIOMARKERS TO PREDICT CLINICAL OUTCOMES IN BCG-TREATED PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
15. MP17-20 BRIDGING GAPS IN BLADDER CANCER: TRANSFORMATIVE EDUCATION EMPOWERS UROLOGISTS TO PROVIDE ENHANCED PATIENT CARE
16. Intravesical Therapy Compared to Radical Cystectomy Among Patients With Non-Muscle Invasive Bladder Cancer Requiring Additional Treatment After Induction BCG
17. Catching Those Who Fall Through the Cracks: Integrating a Follow-Up Process for Emergency Department Patients with Incidental Radiologic Findings
18. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO GUIDELINE (2017; Amended 2020, 2024)
19. Bladder cancer big and small: a multiscale approach to improving sensitivity and specificity
20. EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL
21. COMPARISON OF APIXABAN VERSUS ENOXAPARIN FOR EXTENDED PROPHYLAXIS AFTER RADICAL CYSTECTOMY (CARE)
22. Quality of Life in the Phase 2/3 Trial of N-803 Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin‒Unresponsive Nonmuscle-Invasive Bladder Cancer
23. Time Management
24. Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis
25. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment
26. Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology
27. Implementation of a comprehensive prehabilitation program for patients undergoing radical cystectomy
28. The prevention of extraction site incisional hernia after robotic-assisted radical prostatectomy
29. The Role and Importance of Timely Radical Cystectomy for High-Risk Non-muscle-Invasive Bladder Cancer
30. Polycystic Kidney Disease
31. Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in Medicare
32. Accuracy and Reliability of Chatbot Responses to Physician Questions
33. Commentary on Novitas LCD
34. Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) Study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer
35. Multiparameter interferometric polarization-enhanced imaging differentiates carcinoma in situ from inflammation of the bladder: an ex vivo study
36. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review
37. Role and Indications of Organ-Sparing “Radical” Cystectomy: The Importance of Careful Patient Selection and Counseling
38. Conduit Urinary Diversion
39. Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial
40. ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer
41. Effects of Specialist Palliative Care for Patients Undergoing Major Abdominal Surgery for Cancer
42. Office-based Cystoscopy
43. Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline
44. Intravesical oncolytic virotherapy and immunotherapy for non‐muscle ‐invasive bladder cancer mouse model
45. Bringing blue light cystoscopy to the office: digital staining on matched white and blue light cystoscopy videos (Conference Presentation)
46. Quality of life in QUILT 3.032 study: Patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) receiving IL-15RαFc superagonist N-803 plus BCG.
47. Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model
48. Principles of Bladder Cancer Surgery
49. Treatment of muscle-invasive bladder cancer
50. Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.